Cargando…

Central serous chorioretinopathy in primary hyperaldosteronism

PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11....

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Elon H. C., Nijhoff, Michiel F., de Jong, Eiko K., Meijer, Onno C., de Vries, Aiko P. J., Boon, Camiel J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045484/
https://www.ncbi.nlm.nih.gov/pubmed/27393297
http://dx.doi.org/10.1007/s00417-016-3417-8
_version_ 1782457127620575232
author van Dijk, Elon H. C.
Nijhoff, Michiel F.
de Jong, Eiko K.
Meijer, Onno C.
de Vries, Aiko P. J.
Boon, Camiel J. F.
author_facet van Dijk, Elon H. C.
Nijhoff, Michiel F.
de Jong, Eiko K.
Meijer, Onno C.
de Vries, Aiko P. J.
Boon, Camiel J. F.
author_sort van Dijk, Elon H. C.
collection PubMed
description PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11.0 ± 11.2 years. Ophthalmological imaging revealed macular serous subretinal fluid (SRF) on optical coherence tomography in 2 patients (15 %). In one of these patients, bilateral chronic central serous chorioretinopathy (CSC) with polypoidal choroidal neovasculopathy was diagnosed, which was effectively treated with full-dose photodynamic therapy. In the other patient with SRF and bilateral diffuse hyperfluorescent areas on fluorescein angiography, the SRF had decreased spontaneously after 6 weeks of follow-up. In 5 of the remaining patients (38 %), retinal pigment epithelium alterations resembling findings characteristic for CSC were seen on multimodal imaging. The mean subfoveal choroidal thickness was 290.2 ± 65.0 μm. CONCLUSIONS: Retinal abnormalities resembling (subclinical) CSC are common in patients with PA. These findings indicate that mineralocorticoid-mediated pathways are involved in the pathogenesis of CSC. In CSC patients with hypertension of unknown origin, a diagnosis of PA should be considered.
format Online
Article
Text
id pubmed-5045484
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-50454842016-10-15 Central serous chorioretinopathy in primary hyperaldosteronism van Dijk, Elon H. C. Nijhoff, Michiel F. de Jong, Eiko K. Meijer, Onno C. de Vries, Aiko P. J. Boon, Camiel J. F. Graefes Arch Clin Exp Ophthalmol Medical Ophthalmology PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11.0 ± 11.2 years. Ophthalmological imaging revealed macular serous subretinal fluid (SRF) on optical coherence tomography in 2 patients (15 %). In one of these patients, bilateral chronic central serous chorioretinopathy (CSC) with polypoidal choroidal neovasculopathy was diagnosed, which was effectively treated with full-dose photodynamic therapy. In the other patient with SRF and bilateral diffuse hyperfluorescent areas on fluorescein angiography, the SRF had decreased spontaneously after 6 weeks of follow-up. In 5 of the remaining patients (38 %), retinal pigment epithelium alterations resembling findings characteristic for CSC were seen on multimodal imaging. The mean subfoveal choroidal thickness was 290.2 ± 65.0 μm. CONCLUSIONS: Retinal abnormalities resembling (subclinical) CSC are common in patients with PA. These findings indicate that mineralocorticoid-mediated pathways are involved in the pathogenesis of CSC. In CSC patients with hypertension of unknown origin, a diagnosis of PA should be considered. Springer Berlin Heidelberg 2016-07-08 2016 /pmc/articles/PMC5045484/ /pubmed/27393297 http://dx.doi.org/10.1007/s00417-016-3417-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Medical Ophthalmology
van Dijk, Elon H. C.
Nijhoff, Michiel F.
de Jong, Eiko K.
Meijer, Onno C.
de Vries, Aiko P. J.
Boon, Camiel J. F.
Central serous chorioretinopathy in primary hyperaldosteronism
title Central serous chorioretinopathy in primary hyperaldosteronism
title_full Central serous chorioretinopathy in primary hyperaldosteronism
title_fullStr Central serous chorioretinopathy in primary hyperaldosteronism
title_full_unstemmed Central serous chorioretinopathy in primary hyperaldosteronism
title_short Central serous chorioretinopathy in primary hyperaldosteronism
title_sort central serous chorioretinopathy in primary hyperaldosteronism
topic Medical Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045484/
https://www.ncbi.nlm.nih.gov/pubmed/27393297
http://dx.doi.org/10.1007/s00417-016-3417-8
work_keys_str_mv AT vandijkelonhc centralserouschorioretinopathyinprimaryhyperaldosteronism
AT nijhoffmichielf centralserouschorioretinopathyinprimaryhyperaldosteronism
AT dejongeikok centralserouschorioretinopathyinprimaryhyperaldosteronism
AT meijeronnoc centralserouschorioretinopathyinprimaryhyperaldosteronism
AT devriesaikopj centralserouschorioretinopathyinprimaryhyperaldosteronism
AT booncamieljf centralserouschorioretinopathyinprimaryhyperaldosteronism